Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors.

G-CSF PMN-MDSCs biomarkers cancer patients neutrophils

Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
17 Jan 2024
Historique:
received: 07 03 2023
revised: 11 08 2023
accepted: 18 12 2023
medline: 20 1 2024
pubmed: 20 1 2024
entrez: 19 1 2024
Statut: aheadofprint

Résumé

Precise molecular characterization of circulating polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) is hampered by their mixed composition of mature and immature cells and lack of specific markers. Here, we focus on mature CD66b

Identifiants

DOI: 10.1016/j.xcrm.2023.101380 PMID: 38242120
pubmed: 38242120
pii: S2666-3791(23)00609-2
doi: 10.1016/j.xcrm.2023.101380
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101380

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Francesca Pettinella (F)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Barbara Mariotti (B)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Chiara Lattanzi (C)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Kirsten Bruderek (K)

Research Division, Department of Otorhinolaryngology, University Hospital Essen, 45122 Essen, Germany.

Marta Donini (M)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Sara Costa (S)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Olivia Marini (O)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Giulia Iannoto (G)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Sara Gasperini (S)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Elena Caveggion (E)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Monica Castellucci (M)

Centro Piattaforme Tecnologiche, University of Verona, Verona, Italy.

Federica Calzetti (F)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Francisco Bianchetto-Aguilera (F)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Elisa Gardiman (E)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Matteo Giani (M)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Stefano Dusi (S)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Maurizio Cantini (M)

Transfusion Medicine Department, University and Hospital Trust (AOUI), Verona, Italy.

Aurora Vassanelli (A)

Transfusion Medicine Department, University and Hospital Trust (AOUI), Verona, Italy.

Denise Pavone (D)

Transfusion Medicine Department, University and Hospital Trust (AOUI), Verona, Italy.

Michele Milella (M)

Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.

Sara Pilotto (S)

Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.

Pamela Biondani (P)

Section of Oncology, University and Hospital Trust (AOUI) of Verona, Verona, Italy.

Benedikt Höing (B)

Department of Otorhinolaryngology, University Hospital Essen, Essen, Germany.

Marie Carolin Schleupner (MC)

Department of Otorhinolaryngology, University Hospital Essen, Essen, Germany.

Timon Hussain (T)

Department of Otorhinolaryngology, University Hospital Essen, Essen, Germany.

Boris Hadaschik (B)

Department of Urology, University Hospital Essen, Essen, Germany.

Cordelia Kaspar (C)

Department of Urology, University Hospital Essen, Essen, Germany.

Carlo Visco (C)

Section of Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.

Cristina Tecchio (C)

Section of Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy.

Leo Koenderman (L)

Department of Respiratory Medicine and Center for Translational Immunology, University Medical Center Utrecht, 3584CX Utrecht, the Netherlands.

Flavia Bazzoni (F)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Nicola Tamassia (N)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy.

Sven Brandau (S)

Research Division, Department of Otorhinolaryngology, University Hospital Essen, 45122 Essen, Germany; German Cancer Consortium, Partner Site Essen-Düsseldorf, Essen, Germany.

Marco A Cassatella (MA)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy. Electronic address: marco.cassatella@univr.it.

Patrizia Scapini (P)

Section of General Pathology, Department of Medicine, University of Verona, 37134 Verona, Italy. Electronic address: patrizia.scapini@univr.it.

Classifications MeSH